Search
Cardiolipin Biosynthesis CL(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:1(9Z)/18:0)
smpdb.ca/view/SMP0287731MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition. It is essential for the optimal function of numerous enzymes that are involved in mitochondrial...
Cardiolipin Biosynthesis CL(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)/14:0)
smpdb.ca/view/SMP0287756MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition. It is essential for the optimal function of numerous enzymes that are involved in mitochondrial...
Cardiolipin Biosynthesis CL(22:5(7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/18:1(9Z)/16:0)
smpdb.ca/view/SMP0287757MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition. It is essential for the optimal function of numerous enzymes that are involved in mitochondrial...
Cardiolipin Biosynthesis CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/14:0/18:0)
smpdb.ca/view/SMP0287890MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition. It is essential for the optimal function of numerous enzymes that are involved in mitochondrial...
Cardiolipin Biosynthesis CL(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0/16:0)
smpdb.ca/view/SMP0287903MetabolicCardiolipin (CL) is an important component of the inner mitochondrial membrane where it constitutes about 20% of the total lipid composition. It is essential for the optimal function of numerous enzymes that are involved in mitochondrial...
Acylcarnitine (9S,10R,11E,13S)-9,10,13-trihydroxyoctadec-11-enoylcarnitine
smpdb.ca/view/SMP0124325Metabolic(9S,10R,11E,13S)-9,10,13-trihydroxyoctadec-11-enoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (9S,10R,11E,13S)-9,10,13-trihydroxyoctadec-11-enoyl-CoA reacts with L-carnitine to form (9S,10R,11E,13S)-9,10,13-trihydroxyoctadec-11-enoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAcylcarnitine (7E,10E,13E,16E)-3-Hydroxydocosa-7,10,13,16-tetraenoylcarnitine
smpdb.ca/view/SMP0124399Metabolic(7E,10E,13E,16E)-3-Hydroxydocosa-7,10,13,16-tetraenoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (7E,10E,13E,16E)-3-hydroxydocosa-7,10,13,16-tetraenoyl-CoA reacts with L-carnitine to form (7E,10E,13E,16E)-3-hydroxydocosa-7,10,13,16-tetraenoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 moreAG-24322
go.drugbank.com/drugs/DB13035InvestigationalAG-024322 has been used in trials studying the treatment of Neoplasms and Lymphoma, Non-Hodgkin.
MK-0482
go.drugbank.com/drugs/DB17453InvestigationalMK-0482 is a novel humanized IgG4 monoclonal antibody targeting the immunoglobulin-like transcript (ILT) 3.
Acylcarnitine (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoylcarnitine
smpdb.ca/view/SMP0124402Metabolic(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoylcarnitine is an acylcarnitine. … In forming an acylcarnitine derivative, (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl-CoA reacts with L-carnitine to form (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoylcarnitine.
Drugs: Biotin · Adenosine phosphate · ATP · Levocarnitine · Magnesium cation · Pyrophosphoric acid +1 more